SCHEMBL7658707

SCHEMBL7658707

O=C(Cl)c1c(S)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
HSD17B10 Q99714 4/20 0.42
HPGD P15428 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
KDM4E B2RXH2 2/20 0.42
GLA P06280 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2A6 P11509 2/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PAX8 Q06710 1/20 0.41
WDR5 P61964 1/20 0.40
LDHA P00338 1/20 0.39
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
ABCG2 Q9UNQ0 2/20 0.38
HPRT1 P00492 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200513 0.82 HSD17B10 (0.59) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL1392829 0.81 NCEH1 (0.51) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL6289875 0.79 NCEH1 (0.42) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL3918323 0.78 ABCG2 (0.54) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL608187 0.78 WDR5 (0.50) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL29819980 0.78 WDR5 (0.50) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL6609007 0.78 ALDH1A1 (0.54) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL15829530 0.77 ALDH1A1 (0.42) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL1925120 0.77 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19
SCHEMBL9762785 0.77 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
WO-1998011895-A1 A METHOD FOR THE PREVENTION OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-03-26 WO disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1998006402-A1 TREATMENT OF THE COMMON COLD OR ALLERGIC RHINITIS ELI LILLY AND COMPANY (US) 1998-02-19 WO disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed